Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyun Ju | - |
dc.contributor.author | Chang, Jee Suk | - |
dc.contributor.author | Koom, Woong Sub | - |
dc.contributor.author | Lee, Kyu Chan | - |
dc.contributor.author | Kim, Gwi Eon | - |
dc.contributor.author | Kim, Yong Bae | - |
dc.date.available | 2020-02-27T08:42:39Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2018-11 | - |
dc.identifier.issn | 0090-8258 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/3158 | - |
dc.description.abstract | Objective. The feasibility of salvage radiotherapy (RT) for patients with recurrent cervical cancer after definitive treatment is contentious. The purpose of this study was to investigate the feasibility and benefit of RT, particularly intensity-modulated RT (IMRT), for salvage treatment in patients with recurrent cervical cancer. Methods. We retrospectively analyzed 125 patients with recurrent cervical cancer treated with RT at Yonsei Cancer Center between January 2007 and December 2016. All patients received salvage RT for the recurred or metastatic tumor mass. Irradiating dose and volume were determined depending on initial treatment. IMRT was selected in challenging cases, such as re-irradiation or for patients for whom implementing a satisfactory 3-dimensional conformal RT plan was challenging. Results. The median follow-up period was 5.5 years (range, 10.8 months to 41 years). The 5-year local failure-free survival (LFFS) and progression-free survival (PFS) rates were 63.9% and 39.6%, respectively. The 5-year overall survival (OS) rate was 66%; 10-year OS reached 51%. The median PFS rates in patients with locoregional failure, distant metastases, or both were 45.4, 29.1, and 14.7 months, respectively (p = 0.005). For the 45 patients that received re-irradiation, 5-year LFFS, PFS, and OS rates were 47.1%, 33.2%, and 66.5%, respectively. Late complications were observed in 12 patients (12/125, 9.6%). Conclusions. Our data suggest that salvage RT is safe and effective against recurrent cervical cancer. IMRT is a safe and effective salvage modality for these patients, including those requiring re-irradiation. (C) 2018 Elsevier Inc. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.relation.isPartOf | GYNECOLOGIC ONCOLOGY | - |
dc.subject | UTERINE CERVIX | - |
dc.subject | CARCINOMA | - |
dc.subject | RADIATION | - |
dc.subject | ENDOMETRIAL | - |
dc.subject | PROGNOSIS | - |
dc.subject | SURGERY | - |
dc.title | Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000452939100005 | - |
dc.identifier.doi | 10.1016/j.ygyno.2018.08.029 | - |
dc.identifier.bibliographicCitation | GYNECOLOGIC ONCOLOGY, v.151, no.2, pp.208 - 214 | - |
dc.identifier.scopusid | 2-s2.0-85052873936 | - |
dc.citation.endPage | 214 | - |
dc.citation.startPage | 208 | - |
dc.citation.title | GYNECOLOGIC ONCOLOGY | - |
dc.citation.volume | 151 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Kim, Hyun Ju | - |
dc.contributor.affiliatedAuthor | Lee, Kyu Chan | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Cervical cancer | - |
dc.subject.keywordAuthor | Recurrence | - |
dc.subject.keywordAuthor | Salvage therapy | - |
dc.subject.keywordAuthor | Radiotherapy | - |
dc.subject.keywordAuthor | Intensity-modulated | - |
dc.subject.keywordPlus | UTERINE CERVIX | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | RADIATION | - |
dc.subject.keywordPlus | ENDOMETRIAL | - |
dc.subject.keywordPlus | PROGNOSIS | - |
dc.subject.keywordPlus | SURGERY | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Obstetrics & Gynecology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Obstetrics & Gynecology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.